How I faced my prostate cancer: a molecular biologist’s perspective

Hippocrates (Kos, c.460–c.370 BC) reminds us that “It is more important to know what sort of person has a disease than to know what sort of disease a person has”. This is still true today and reflects the emerging role of personalized medicine for patient-specific risk stratification and treatment p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	NPJ precision oncology 2021-09, Vol.5 (1), p.88-88, Article 88
Hauptverfasser:	Zuradelli, Monica, Lazzeri, Massimo, Lopci, Egesta, Zucali, Paolo Andrea, Balzarini, Luca, Guazzoni, Giorgio, Colombo, Piergiuseppe, Scorsetti, Marta, Franzese, Ciro, Asselta, Rosanna, Soldà, Giulia, Duga, Stefano
Format:	Artikel
Sprache:	eng
Schlagworte:	692/4017 692/4028/67 Cancer Research Comment Gene Therapy Health psychology Human Genetics Internal Medicine Medicine Medicine & Public Health Molecular biology Oncology Patients Precision medicine Prostate cancer Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Hippocrates (Kos, c.460–c.370 BC) reminds us that “It is more important to know what sort of person has a disease than to know what sort of disease a person has”. This is still true today and reflects the emerging role of personalized medicine for patient-specific risk stratification and treatment programs. This report documents my personal experience as a patient with aggressive prostate cancer, who, as a scientist, had the privilege to access cutting-edge medical care and molecular profiling.
ISSN:	2397-768X 2397-768X
DOI:	10.1038/s41698-021-00229-5